Page 77 - CIBERDEM2016-ENG

Most relevant scientific articles
• Menéndez E, Delgado E, Fernández-Vega F, Prieto MA, Bordiú E, Calle A et al. Prevalence, Diagnosis, Treatment, and Control of Hypertension in Spain. Results of the [email protected] Study. Revista española de cardiología (English ed.). 2016;69(6):572-8.
• Olveira G., Tapia M.J., Ocon J., Cabrejas-Gómez C., Ballesteros-Pomar M.D., Vidal-Casariego A. et al. Hypoglycemia in noncritically ill patients receiving total parenteral nutrition: A multicenter study. (Study group on the problem of hyperglycemia in parenteral nutrition; nutrition area of the Spanish Society of Endocrinology and Nutrition). Nutrition. 2016;31(1):58-63.
• Bermúdez-Silva F.J., Romero-Zerbo S.Y., Haissaguerre M., Ruz-Maldonado I., Lhamyani S., El Bekay R. et al. The cannabinoid CB1 receptor and mTORC1 signalling pathways interact to modulate glucose homeostasis in mice. DMM Disease Models and Mechanisms. 2016;9(1):51-61.
• Brugnara L., Murillo S., Novials A., Rojo-Martínez G., Soriguer F., Goday A. et al. Low physical activity and its association with diabetes and other cardiovascular risk factors: A nationwide, population-based study. PLoS ONE. 2016;11(8).
• Balfego M., Canivell S., Hanzu F.A., Sala-Vila A., Martínez-Medina M., Murillo S. et al. Effects of sardine-enriched diet on metabolic control, inflammation and gut microbiota in drug-naïve patients with type 2 diabetes: A pilot randomized trial. Lipids in Health and Disease. 2016;15(1).
Highlights
During 2016, the field work of the [email protected] study has been organized and launched. This project will determine the incidence of diabetes and associated metabolic diseases in Spain.
The integrated project of excellence PIE14/00031 that will determine the metabolic profiles associated with the presence of metabolic syndrome in several clinical projects has been developed.
A project has also been initiated on the beneficial actions of phenolic compounds of extra virgin olive oil in pancreatic islets and their impact on the prevention of type 2 diabetes, with regional funding.
One Research Contract (Service Agreement) has been signed with INSERM regarding collaboration with Dr. Daniela Cota (U1215, Bordeaux, France).
The group participates in the European Union’s DEDIPAC and EnPADASI actions.
DEM
research groups 77